In this study we describe the isolation of Xcadherin-11, the Xenopus homologue to the mesenchymal cadherin-11. Similar to epithelial and neural cadherins, overexpression of Xcadherin-11 led to posteriorised phenotypes due to inhibition of convergent extension movement. Because zygotic expression of Xcadherin-11 starts with gastrulation, we analysed the ability of different growth factors involved in mesoderm differentiation to induce the expression of Xcadherin-11. Using the animal cap assay, we demonstrated that Xcadherin-11 is activated by Xwnt-8 or b-catenin, but repressed by BMP-4. Activin did not induce Xcadherin-11 but its synergistic function was required for the Xwnt-8/b-catenin-mediated activation of Xcadherin-11. Because Xcadherin-11 and Xenopus E-and N-cadherin are differentially regulated by growth factors in the Xenopus animal cap, our results also reveal that this assay provides a helpful model system to elucidate the molecular control mechanism of epithelial-mesenchymal conversion.
Introduction
Cadherins represent a multigene family of calciumdependent glycoproteins mediating cell-cell adhesion. Members of the cadherin superfamily have been classified in several categories based on sequence alignment, including type I and type II cadherins, desmosomal cadherins, protocadherins and cadherin-related proteins (Suzuki, 1996) . Members of the cadherin type I and type II subfamilies are expressed differentially during development. Their individual expression patterns correlate with distinct morphogenetic events such as cell migration and tissue segregation Suzuki, 1996) . Although the activity of the type I family in cell adhesion and cell differentiation and its functional requirement for embryonic development is well defined, little is known about the contribution of the type II family to these processes. Of particular interest among the type II family members is mouse cadherin-11, which is homologous to human cadherin-11 (Tanihara et al., 1994) and to the closely-related murine and human OB-cadherins (Okazaki et al., 1994) . Murine cadherin-11 is strongly expressed in the mesoderm during gastrulation and in dispersed migrating mesenchymal cells that originate from neural crest cells (Hoffmann and Balling, 1995; Kimura et al., 1995 Kimura et al., , 1996 . The cadherin-like adhesive properties of the murine cadherin-11 protein were demonstrated when it was exogenously expressed in fibroblasts (Kimura et al., 1995) . Cadherin-11 seems to be the major mesenchymal cadherin excluded from all epithelial tissues (Hoffmann and Balling, 1995; Simonneau et al., 1995) , thereby providing a useful tool to study epithelialmesenchymal transitions. Based on the observations that (i) loss of E-cadherin expression correlates with increase of LEF-1 transcripts and that (ii) LEF-1 binds to the E-cadherin promoter, Huber et al. speculate that the Wg/Wnt signal transducers b-catenin/LEF-1 might downregulate Ecadherin expression while mesenchymal genes might be activated (Huber et al., 1996a,b) . LEF-1 knock-out mice developed severe defects in organs which require ectodermal-mesenchymal tissue interactions during differentiation (van Genderen et al., 1994) . These observations were supported by recent reports (Kratochwil et al., 1996) demonstrating that a transient expression of LEF-1 being activated by BMP-4 is essential for tooth and whisker development, Fig. 1 . Sequence of Xcadherin-11 cDNA. Deduced protein sequence is written above the nucleotide sequence. Positions of the five extracellular domains are indicated by arrows, the box marks the putative transmembrane domain, encircled N a putative glycosylation site. Tripeptide QAV within the EC1 domain is encircled. Sequence data presented in this paper have been submitted to the GenBank data library under the accession number AF002983.
both excellent examples of epithelial-mesenchymal interactions.
In early Xenopus development, the same signal pathways, BMP-4 and Wg/Wnt, act in concert with other factorsactivin, noggin, chordin -during dorsoventral patterning of the mesoderm. The mesoderm is ventralised by BMP-4 while activin, noggin and chordin induce its dorsalisation (for review see Dawid, 1994; Lemaire and Gurdon, 1994; Slack, 1994) . Several members of the Wnt-family have been identified, forming two subfamilies of different functions (Moon, 1993; Du et al., 1995) . Xwnt-8 represents the subfamily which activates, like wingless in Drosophila, the Wg/Wnt signalling cascade which comprises the components dishevelled, glycogen synthase kinase, b-catenin/ armadillo and LEF1/XTcf3/pangolin (Gumbiner, 1995; Miller and Moon, 1996; Kühl and Wedlich, 1997) . For all these components, except the HMG transcription factors XTcf-3 and pangolin, it was demonstrated that they are able to induce a secondary axis in the Xenopus embryo when they are expressed at the ventral side before mid-blastula transition (MBT).
Until the gastrula stage, embryonic cells are of unique epithelial-like character. Within the process of mesoderm formation, this subpopulation of cells changes its properties from epithelial towards more loosely-associated and motile cells. Growth factors responsible for mesoderm induction and patterning also reduce cell-cell adhesion and stimulate cellular motility (Smith et al., 1990; Howard and Smith, 1993; Brieher and Gumbiner, 1994) . In an extended sense, mesoderm induction can be taken as the first example in ontogenesis of an epithelial-mesenchymal conversion (Birchmeier and Birchmeier, 1993) . This addresses the intriguing question whether the regulation of mesenchymal genes by inducing-factors during Xenopus development could provide new insights into the molecular control mechanisms of epithelial-mesenchymal conversions in tissue differentiation.
Here, we report the cloning of the Xenopus homologue of the mesenchymal cadherin-11 (Xcadherin-11) and confirm its cadherin-like property by overexpression in Xenopus embryos. We also demonstrate that Xcadherin-11 is induced by Xwnt-8 and b-catenin only in presence of activin, whereas it is suppressed by BMP-4. These findings suggest that mesenchymal genes might be controlled by synergistical interactions of Wg/Wnt and TGF-b signalling pathways.
Results

Cloning of Xcadherin-11
Based on multiple alignment of all known cadherin sequences using the DNA-STAR megalign software, motifs specific for type II cadherins were identified and used to design degenerated primers, carefully chosen to exclude the amplification of Xenopus F-cadherin. The latter was formerly characterised as a type II cadherin highly specific for flexures in neural tissues (Espeseth et al., 1995) . Amplified reverse transcriptase-polymerase chain reaction (RT-PCR) fragments obtained from tailbud-stage RNA were sequenced. A 560-bp fragment encoding a cadherin-11 homologue was used to screen a Lambda ZAP II Library of stage-30 Xenopus embryos. In total, we isolated 11 independent cDNA clones each of different size. They could be divided into two subgroups because three and eight cDNA clones, respectively, were of identical sequence. Since the sequences between the subgroups only differed by 2.7%, they might represent two different alleles of Xcadherin-11. The largest cDNA clone, containing a complete Xcadherin-11 sequence of 3237 bp was further analysed. This clone encoded a putative protein of 783 amino acids (Fig.  1) . Sequence analysis revealed amino-acid identity of the putative Xcadherin-11 to murine cadherin-11 and human OB-cadherin of 83% (Table 1 ). Similar to the murine and human molecules, Xcadherin-11 consists of five extracellular domains with four Ca 2+ binding motifs. Most mismatches (39-40%) to the mammalian homologues were observed in the EC5 domain whereas only 14 (10-12%) amino acid exchanges were found in the cytoplasmic domain (Table  1) . Instead of the HAV motif present in the EC1 domain, Xcadherin-11 contains the tripeptide QAV common to most of the type II cadherins (Fig. 1) . Although the overall identity of the b-catenin binding site in the cytoplasmic tail between Xcadherin-11 and mouse/dog E-cadherin (Stappert and Kemler, 1994; Jou et al., 1995) or Xenopus XB/U-cadherin (Finnemann et al., 1997 ) is only about 54%, this region contains a series of six highly-conserved serine residues. When the complete predicted Xcadherin-11 protein sequence was compared with Xenopus cadherins we observed a closer relationship to the type II Xenopus F cadherin than to the type I cadherins, E-, XB/U-or N-cadherin (Table 1) .
Zygotic expression of Xcadherln-11 starts at gastrulation and is restricted to the anterior part of the embryo
The developmental expression profile of Xcadherin-11 was studied by RT-PCR in combination with Southern blotting. A basal maternal expression was found before MBT, while zygotic transcription started at mid-gastrulation and reached its maximum at the tailbud stage ( Fig. 2A) . Dissection of embryos at different developmental stages revealed that at the blastula stage most of the maternal transcripts were localised in the animal cap (Fig. 2B) . At the neurula stage most of the transcripts were found in the neural plate and the underlying mesoderm (Fig. 2C) . At later stages, Xcadherin-11 mRNA was predominantly located in the head and dorsal part of the embryo (Fig. 2D) . Wholemount in situ hybridisations of albino embryos confirmed our RT-PCR results. As shown in Fig. 3A ,B, only a slight staining of the animal hemisphere was seen at the blastula stage. At the gastrula stage the staining was more intense and was spread over the entire animal and marginal hemisphere, with the exception of the endoderm (Fig. 3C,D) . By stage 23, Xcadherin-11 transcripts were found specifically localised in migrating cranial neural crest cells labelling the mandibular and branchial crest segments (Fig. 3E,G ). In the trunk region, Xcadherin-11 was expressed in the entire lateral mesoderm (Fig. 3I) . At tailbud stage 28, Xcadherin-11 transcripts were predominantly observed in the head region where its expression was clearly organised into the mandibular, hyoidal and branchial crest segments (Fig. 3F) . The stained tissue surrounding the eye anlagen corresponds to the dorsal and the caudoventral portions of the mandibular crest segment ( Fig. 3F,H ; see also Sadaghiani and Thièbaud, 1987) . Transverse sections revealed that epidermis, brain, notochord, myotome and gut were negative for Xcadherin-11 while the sclerotome, somatic and splanchnic layers of the lateral mesoderm showed Xcadherin-11 staining (Fig.  3J ).
Xcadherln-11 is induced by Xwnt-8 and suppressed by BMP-4
In order to determine if Xcadherin-11 expression is controlled by factors patterning the mesoderm, we overexpressed Xwnt-8 at the ventral side or BMP-4 at the dorsal side of Xenopus embryos and analysed Xcadherin-11 expression by RT-PCR. As shown in Fig. 2E , Xcadherin-11 was induced by Xwnt-8 and repressed by BMP-4. Because endogenous mesodermal inducing factors like vg1, activin and eFGF, which are already present in the unfertilised egg, might contribute to the activation of Xcadherin-11, we used the animal cap assay to investigate the regulation of Xcadherin-11 expression in more detail. Animal caps from embryos injected with Xwnt-8, b-catenin, siamois or BMP-4 RNA were cultivated in the presence or absence of activin and analysed for Xcadherin-11 expression by RT-PCR in comparison with the pattern found for the type I cadherins, e.g. E-and N-cadherin. As a control, embryos were injected with preprolactin RNA.
Xcadherin-11 transcription was activated by Xwnt-8 and b-catenin, but only in the presence of activin. Activin itself did not show any effect (Fig. 4, upper row) . Most interestingly, the homeobox transcription factor siamois, a target gene of the Xwnt-8 signalling cascade, failed to activate Xcadherin-11 transcription (Fig. 4, left lane) . BMP-4 repressed Xcadherin-11 expression irrespective of whether activin was present or not. E-cadherin expression was completely independent of the presence of Xwnt-8, b-catenin, siamois and BMP-4 (Fig. 4 , middle row). Also, activin had no influence on E-cadherin transcription, neither alone nor in combination with any of the other factors. N-cadherin, in contrast to Xcadherin-11 and E-cadherin, was induced by activin alone (see preprolactin lanes, Fig. 4 , lower row). Expression of Xwnt-8 or b-catenin in animal caps did not increase the activin-induced level of N-cadherin transcripts, indicating that this cadherin is not regulated by the Wg/Wnt signalling pathway. Activin induced N-cadherin expression was repressed when siamois or BMP-4 RNA was injected (Fig. 4, lower row) . Fig. 4 . Control of Xcadherin-11 expression by different inducing factors using the animal cap assay. Overexpression of b-catenin or Xwnt-8 in the presence of activin increased Xcadherin-11 expression but did not alter the expression of E-cadherin. N-cadherin was induced after treatment with activin alone. Siamois, b-catenin, Xwnt-8, BMP-4, or preprolactin mRNA were injected into the animal pole of each blastomere of a 2-cell stage embryo and cultured until stage 6.5. Animal caps were prepared at stage 7, treated with or without activin and cultured until stage 17 of control embryos. Expression of Xcadherin-11, E-cadherin, N-cadherin and EF-1a was assayed by RT-PCR. For controls equivalent aliquots of RNA from each sample (four animal caps) were analysed in the absence of reverse transcriptase (RT). The upper row shows the expression level of Xcadherin-11 and the internal standard of EF-1a. b-catenin and Xwnt-8, but not siamois, increased the expression of Xcadherin-11. Activin alone (see preprolactin-injected control) did not induce Xcadherin-11, but was required for the b-catenin and Xwnt-8 effect. BMP-4 repressed Xcadherin-11 expression. Middle row shows that E-cadherin expression was not changed by inducing factors. The lower row shows N-cadherin induction after treatment with activin. Neither b-catenin nor Xwnt-8 injection led to a further increase in expression, whereas BMP-4 and siamois abolished activin induced expression.
Overexpression of Xcadherin-11 led to posteriorised phenotypes with strong defects in head formation
Injection of Xcadherin-11 RNA into the marginal zone of both dorsal blastomeres at the 4-cell stage gave rise to posteriorised phenotypes with strong malformations of head structures (Fig. 5) . High doses of injected RNA (0.7 ng) led to complete loss of heads ( Fig. 5A ; Table 2 ). Histologi- cal analysis revealed an amorphous structure of the brain. Eye anlagen were not formed and otic vesicles were found as single organ anlagen (Fig. 5B-D) . In some embryos, the notochord was missing (Fig. 5C-E) , which caused the fusion of both lateral somitic mesoderm bands. Embryos injected with lower amounts of Xcadherin-11 RNA (0.35 ng) showed less severe defects in tissue organisation ( Fig.  5F-J) . Their heads and eyes were reduced in size (Fig. 5F ), eyes were not completely separated from the diencephalon (Fig. 5G) , the notochord appeared enlarged compared with controls (compare Fig. 5I ,J with Fig. 5N,O) . In the trunk region, the neural tube was reduced and in direct contact with the notochord (Fig. 5J) . To prove the differentiation of notochord and neural tissue embryos were stained with Tor-70 and N-CAM antibodies. In embryos injected with 0.7 ng Xcadherin-11 mRNA, nerve fibres in the trunk were formed normally (Fig. 6A ,B arrowhead) whereas in the anterior region they were absent. The reduced neural tube was found more ventrally in close proximity to the notochord (arrows in Fig. 6A,B) . The formation of the notochord appeared quite normal in the trunk regions of embryos injected with low doses of Xcadherin-11 (0.35 ng). However, the notochord was elongated and kinked in the heads of these embryos (Fig. 6C,D, asterisk) . In addition, some Tor-70 positive vesicles lining the notochord were observed (Fig. 6D, arrows) .
The appearance of posteriorised phenotypes with reduced or even no head formation (Fig. 5A,F) , following Xcadherin-11 overexpression at the dorsal side, could be explained by an effect on adhesion or Wg/Wnt signalling, which we examined by different rescue experiments. Overexpression of Xcadherin-11 might increase cell-cell adhesion which could disturb the adhesive balance of migrating cells during gastrulation. We tried to abolish an increased adhesion by co-injection of cytoplasmically-deleted XB/Ucadherin (XB/UDc38) RNA.
Previously, we have demonstrated that this mutant fails to confer adhesiveness to cells (Finnemann et al., 1997) and that it blocks gastrulation movements . As seen in Table 3 , the optimal concentration to observe rescued embryos was 0.5 ng XB/UDc38 RNA in combination with 1 ng Xcadherin-11 RNA. Suboptimal concentrations led to severe gastrulation defects (1 ng XB/UDc38 RNA) or an increase in ventralised embryos. The latter effect might be due to depletion of b-catenin from the Wg/Wnt signalling cascade by Xcadherin-11 as it was reported for EP/CCadherin (Fagotto et al., 1996) .
Posteriorised phenotypes of Xcadherin-11 RNA-injected embryos could also arise by withdrawal of the Wg/Wnt signal transducer b-catenin from the cytosolic pool. To prove this hypothesis we tried to rescue the posteriorised Xcadherin-11 phenotype by co-injection of b-catenin RNA. Replenishing the endogenous b-catenin pool by co-injection of 20 pg b-catenin RNA resulted in nearly 95% normal phenotype (Table 3) . However, the best rescue effect was observed when b-catenin in combination with the cytoplasmically-deleted cadherin mutant XB/UDc38 was injected, indicating that the posteriorised phenotype is caused by a combination of defects in adhesion and Wg/Wnt signalling.
Overexpression of Xcadherin-11 inhibits convergent extension movements in the upper blastopore lip
As posteriorised phenotypes often arise by perturbation of gastrulation movements, we were interested in whether overexpression of Xcadherin-11 alters the ability of the dorsal marginal zone to undergo convergent extension movement. Lateral intercalation of cells within the marginal zone is the basis of convergent extension movement which becomes obvious in the anterior-posterior elongation of the embryo. During Xenopus gastrulation, it is the main driving force of the mesoderm invagination (Keller, 1986; Winklbauer, 1994) . Explants of the upper blastopore lip from Xcadherin-11 or preprolactin-injected and uninjected embryos were cultured for 24 h under a piece of cover glass to test their convergent extension behaviour. Of the explants, 35 out of 53 (66%) derived from Xcadherin-11-injected embryos, showed no convergent extension movement. These explants did not elongate or narrow (Fig. 7F ) compared with the controls (Fig. 7B,D) . Explants from uninjected and preprolactin-injected control embryos showed in 95% and 87%, respectively, of the preparations, normal convergent extension movement (Fig. 7B,C) .
Discussion
Here, we report the isolation of Xcadherin-11 and its regulation by the Wg/Wnt signalling pathway. Sequence alignment revealed that Xcadherin-11 is the homologue to murine and human cadherin-11/OB-cadherin. The identity to these mammalian cadherins is higher than to other known Xenopus cadherins (Table 1) . Xcadherin-11 is maternally expressed at a low level; transcription increases with gastrulation (Fig. 2) . At early stages, Xcadherin-11 RNA is localised in the animal hemisphere, whereas later in the tailbud stage expression is observed in cranial neural crest cells, sclerotome and lateral mesoderm (Fig. 3) . This distribution parallels the pattern observed in mouse (Hoffmann and Balling, 1995; Kimura et al., 1995; Simonneau et al., 1995) . Overexpression of Xcadherin-11 at the dorsal side revealed similar phenotypes to those obtained after overexpression of full-length type I cadherins, e.g. XB/U-cadherin, EP/C-cadherin, and their cytoplasmic deletion mutants (Dufour et al., 1994; . They all gave rise to posteriorised embryos with severe defects in head-structure formation. In all of these embryos, convergent extension movement of the mesoderm is repressed (Lee and Gumbiner, 1995; . This phe- notype could be explained by (i) alteration in adhesive strength or by (ii) depletion of b-catenin from the Wg/ Wnt signalling pathway. Since co-injection of the XB/Ucadherin mutant (XB/UDc38), lacking the b-catenin binding site, as well as co-injection of b-catenin, led to rescue of the posteriorised phenotype, we conclude that overexpression of Xcadherin-11 increases cell-cell adhesion and weakens Wg/Wnt signalling during dorsoventral axis formation. Our interpretation is strengthened by the findings that co-injection of XB/UDc38 in combination with b-catenin enhanced the rescue effect.
The most exciting result of our study is the regulation of Xcadherin-11 expression by the Wg/Wnt signal. Xwnt-8 induces Xcadherin-11 expression in the embryo (Fig. 2E) and also in the animal cap assay. However, Xwnt-8 itself is not sufficient to activate Xcadherin-11, it requires an activin-like synergistic activity (Fig. 4) . Interestingly, activin alone has no effect on Xcadherin-11, as demonstrated in the animal cap assay (see preprolactin control in Fig. 4 ). In the intact embryo, Xwnt-8 might co-operate with vg1, a maternal activin-like factor (Dale et al., 1989) when it is overexpressed at the ventral side (Fig. 2E) . b-catenin, a downstream component of the Wg/Wnt signalling pathway, also induces Xcadherin-11 (Fig. 4) . Surprisingly, the homeobox transcription factor siamois, a target gene of the Xwnt-8 signal, does not control Xcadherin-11 expression, either in the presence or the absence of activin (Fig. 4) . Thus, Xcadherin-11 synthesis might be directly regulated by b-catenin/XTcf-3. The overlapping distribution of Xcadherin-11 and XTcf-3 transcripts supports this idea (Molenaar et al., 1996) . It raises the interesting possibility that the Xcadherin-11 promoter might contain a LEF-1/Tcf-3 target site. At present, it is still unknown whether Xwnt-8 or a different member of this signal-subfamily, or even b-catenin itself, serves as the endogenous signal to induce Xcadherin-11. Taking into consideration the distribution of Xwnt-8 and its dorsal and ventral antagonists frzb (Leyns et al., 1997) and sizzled (Salic et al., 1997) , the putative local activity of Xwnt-8 correlates with the Xcadherin-11 expression in the lateral mesoderm.
BMP-4, a mesoderm ventralising factor (Köster et al., 1991; Dale et al., 1992; Jones et al., 1992) , acts as a negative regulator of Xcadherin-11 expression (Fig. 4) which corresponds to its recently-identified function as inducer of epidermis (Wilson and Hemmati-Brivanlou, 1995; Suzuki et al., 1997) . Activin blocks epidermis induction, and shifts the cell fate to the mesodermal state (Asashima et al., 1990; Wilson and Hemmati-Brivanlou, 1995) . Xwnt-8 and its target gene siamois are competence modifiers regulating the responsiveness of cells to growth factors (Moon and Christian, 1992; Sokol, 1993; Carnac et al., 1996) , which explains the requirement of activin for the Wg/Wnt-induced Xcadherin-11 expression. A different expression profile was observed for E-cadherin and N-cadherin: E-cadherin expression did not change when animal caps were treated with activin, BMP-4, Xwnt-8, b-catenin or siamois, whereas N-cadherin was induced by activin alone. The stability of E-cadherin expression might be due to BMP-4, which is endogenously present in untreated animal caps. The amount of endogenous BMP4 seems to be sufficient to induce the formation of epidermis independently of the presence of activin or components of the Wg/Wnt signalling cascade. Since BMP-4 also induces ventral mesoderm, overexpression of BMP-4 itself does not result in an excess of epidermis formation. In contrast to Ecadherin, N-cadherin is suppressed by BMP-4 (Fig. 4) . Since N-cadherin is found in notochord and neural tissues, we cannot distinguish between mesoderm induction and secondary neural induction. However, our results show that N-cadherin is differently controlled than Xcadherin-11: its induction by activin was not enhanced by the Wg/ Wnt signalling pathway.
In conclusion, the activation of Xcadherin-11 by Xwnt-8/ b-catenin and its repression by BMP-4, an inducer of the epithelial tissue epidermis, confirms the idea that Xcadherin-11 is a mesenchymal cadherin. Because b-catenin, but not siamois, activates Xcadherin-11 (Fig. 4) we suggest that its expression is controlled by b-catenin in co-operation with the transcription factor XTcf-3. In contrast to murine E-cadherin which might be downregulated by b-catenin/ LEF-1 binding to its promoter (Huber et al., 1996a,b) we would expect an upregulation of Xcadherin-11 by the same Table 3 Xcadherin-11 phenotype is rescued by co-injection of b-catenin or cytoplasmically deleted XB/U-cadherin 
Experimental procedures
Cloning of Xcadherin-11 cDNA
To clone cadherin cDNAs we carried out RT-PCR using degenerated primers specific for the extracellular domain of cadherins type II: X1A (5′...GCI GAY GAY CCI ACI TAY GGI AA...3′) and X1B (5′...ACI GTI GCI GTR TCY TTR AAI GG...3′). Total RNA (RNeasy kit, Qiagen, Valencia, USA) of Xenopus embryos stage 30 were used for RT-PCR. PCR products were cloned (pCR-Script cloning kit, Stratagene, La Jolla, USA) and 40 clones were sequenced (Thermo Sequenase fluorescent labelled primer cycle sequencing kit, Amersham, Braun-Schweig, Germany). A PCR fragment of 560 bp homologous to human and mouse cadherin-11/OB-cadherin was used to screen a Lambda ZAP II Library stage 30 of Xenopus embryos (Stratagene). Positive clones were isolated, and excised into plasmids following the Lambda ZAP II Library instruction manual (Stratagene). After restriction analysis with EcoRI, 12 clones with inserts of 3.3 kb were subcloned and sequenced. Nucleotide and protein sequences were analysed using MacMolly software by Soft Gene, Berlin, Germany and MegAlign software by DNA-STAR, Berlin, Germany.
Reverse transcriptase-polymerase chain reaction
The extracellular domain of Xcadherin-11, which has little similarity with other cadherins, was used to design specific primers for RT-PCR: X11-1 (5′...CTA AGG CAA TCA TTC CAT GGT CA...3′) and X11-2 (5′...ACA TTG GCG TGG TAA GTT TCA TG...3′). RNA from embryos at different stages or from explants was isolated as described by . Five micrograms of total RNA were used to perform standard RT-PCR. The expected length of RT-PCR products was 360 bp. RT-PCR products were analysed by Southern blotting using a 32 P-labelled probe of Xcadherin-11.
To detect type I cadherins the following primers were used for RT-PCR: Xenopus E-cadherin: E1 (5′...AAA TCC AGC TAT GCA AAA GAA GTC...3′), E2 (5′...TCT AGC GTG TTG TTG ACG ATG TC...3′); Xenopus N-cadherin: N1 (5′...GAC CGC GAT AAA AGC CTT TCC CTA...3′), N2 (5′...GTT GGC TAC TAC TAC ATC AAC TCT...3′) and the control EF-1a: C1 (5′...CAG ATT GGT GCT GGA TAT GC...3′), C2 (5′…ACT GCC TTG ATG ACT CCT AG...3′).
Injection of Xenopus embryos
BMP-4, Xwnt-8 and Xcadherin-11 were cloned into pSP64T3 vector for in vitro transcription. In vitro transcribed mRNA (0.5 ng) (mCAP mRNA capping kit, Stratagene) of BMP-4, 0.35/0.7/1 ng of Xcadherin-11, 20 pg of Xwnt-8 or 20 pg of siamois were injected into dorsal (BMP-4, Xcadherin-11) or ventral (Xwnt8) blastomeres of 4-cell stage embryos as described or into the animal pole of both blastomeres of 2-cell stage embryos. The activity of BMP-4, Xwnt-8 and siamois RNA was controlled by phenotype analysis. For rescue experiments the cytoplasmically-truncated mutant XB/UDc38 described elsewhere was co-injected. Embryos were obtained by in vitro fertilisation and cultivated according to . Injected and control embryos were maintained until stage 14 or 30 and then analysed by RT-PCR.
Animal cap assay
Animal caps were prepared from blastula stage 7 Xenopus laevis embryos. The caps were incubated either in the absence or the presence of 30 ng/ml activin A (Asashima et al., 1990) in 1× MBSH (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 0.8 mM MgSO 4 , 0.33 Ca(NO 3 ) 2 , 0.4 mM CaCl 2 , 20 mM HEPES, pH 7.4) and 0.1% BSA. After 3 h caps were transferred to 1× MBSH and cultured until the control embryos reached stage 17. Total RNA was isolated from batches of four animal caps and subjected to RT-PCR.
Histology and whole-mount immunostaining
For histology, embryos were fixed in a solution of 3% paraformaldehyde and 2.5% glutaraldehyde in APBS (amphibian phosphate-buffered saline, 2.7 mM KCl, 0.15 mM KH 2 PO 4 , 103 mM NaCl, 0.7 mM Na 2 HPO 4 , pH 7.5) for 2 h at room temperature. Following washing and dehydration with methanol they were embedded in paraffin. Sections of 6 mm were collected on gelatine-coated slides, deparaffined in xylene, rehydrated and stained with BoraxCarmine and Anilin-Orange prior to mounting in Eukitt (Serva, Heidelberg, Germany).
For whole-mount immunostaining, vitelline membranefree embryos were fixed for 2 h at room temperature in 3.7% formaldehyde in MEMFA (0.1 M MOPS, 2mM EGTA; 1mM MgSO 4 ). Embryos were washed with APBS containing 1% TritionX-100 and 1% BSA (APBT) and blocked with APBT containing 10% lamb serum. After incubation with the first antibody (Tor-70, anti N-CAM) overnight at 4°C they were washed for 4 h. Embryos were incubated with the second antibody, horseradish peroxidase-conjugated goat-anti-mouse-Ig (Dianova, Hamburg, Germany), over-night at 4°C and extensively washed over several hours before they were equilibrated for 15 min with DAB (Diaminobenzidin 0.5 mg/ml). They were transferred to DAB containing 0.01% hydroxyperoxide. To reduce pigmentation, embryos were bleached with 10% H 2 O 2 in methanol for 24 h.
Antibodies
Mouse monoclonal antibody Tor-70, recognising notochord, was a gift from R. Harland, University of California, Berkley, CA. Mouse monoclonal antibody Z191, directed against chicken N-CAM was provided by S. Henke-Fahle, University of Tübingen. For immunostaining undiluted supernatants of the hybridomas were used. (Keller, 1986) In vitro-transcribed mRNA of Xcadherin-11 or preprolactin (700 pg) was injected in each dorsal blastomere of 4-cell stage embryos and explants of the dorsal upper blastopore lip were prepared at stage 10.5. The explants (0.25 mm 2 ) were cultivated for 24 h at 18°C under a piece of cover glass in 1× MBSH (modified Barth solution: 10 mM HEPES, 88 mM NaCl, 1 mM KCl, 0.33 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , 0.82 mM MgSO 4 , 2.4 mM NaHCO 3 , pH 7.4).
Open face explants
